- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Articles That Gained the Most Traction on Facebook, Twitter, and LinkedIn in 2017
Articles on type 2 diabetes management, colon cancer screenings, and anti-rheumatic drug approvals topped the list.
Articles on changing the paradigm of type 2 diabetes management, approaches to colon cancer screening, and approvals of anti-rheumatic drugs were among the most popular articles on social media in 2017. The American Journal of Managed Care® (AJMC®) thanks everyone who is a part of the franchise’s social media platforms and who shared, liked, and promoted original research, news, and more all year long.
If you aren't a part of AJMC®'s social network, join now!
Evidence-Based Oncology™ Twitter
Evidence-Based Diabetes Management™ Twitter
3. Healthy, but Still Hurting: Challenges of Cancer Survivorship
In an interview with AJMC®, Samantha Watson, the CEO and founder of The Samfund, discussed the lingering challenges she faced following being cured of cancer. While many people assumed she was fine because her treatment was finished and her hair grew back, Watson felt stress over finances and emotional and physical issues. Watson found that it was tough to have conversations with anyone about the challenges she was facing.
2. Texas Hospitals Use Social Networks to Seek Volunteer Nurses for Hurricane Relief Efforts
In the aftermath of Hurricane Harvey, hospitals in Texas were recruiting nurses from across the country through the use of social media. The Association of Women’s Health, Obstetric and Neonatal Nurses asked on behalf of Texas health systems for nurses registered to work in neonatal intensive care units “to help provide relief for those who have been working countless hours since Hurricane Harvey made landfall last Friday.”
1. Contributor: Type 2 Diabetes—Changing the Paradigm From Management to Reversal (Sarah Hallberg)
Results from an ongoing 2-year clinical trial collaboration between Virta Health and Indiana University Health suggested that the historic dietary approach to management of type 2 diabetes has been all wrong. The study indicated that diabetes can be reversed while reducing medication and without the risk, cost, or side effects of bariatric surgery. Additionally, reversal can happen in a large percentage of patients, not only outliers.
3. Twitter Accounts Followed by Congressional Health Staff
A study published in the July issue of AJMC® found that health-related and academic sources are largely absent from Twitter conversations with US congressional health policy staff. Takeaway points from the study included that many Congressional health staff are Twitter users, but they are much more likely to follow traditional news media rather than academic or health-specific sources; therefore, even with social media, traditional and political news media are important targets for research dissemination.
2. Contributor: Driving Value With Innovative Approaches to Colon Cancer Screening (Jim Thomson)
AJMC.com contributor Jim Thomson discussed the issue that although national guidelines call for men and women at average risk for colorectal cancer (CRC) to begin screening at age 50, by some estimates, compliance is only at 38%. This means that in more than half of all cases, CRC is not diagnosed until the late stages, when treatment is both difficult and expensive and survival rates are low, according to Thomson.
1. Contributor: Type 2 Diabetes—Changing the Paradigm From Management to Reversal (Sarah Hallberg)
Also coming in as the most popular article for Twitter, the contributor article pushed for a change of the dialogue surrounding type 2 diabetes. This means not just talking about prescriptions or procedures, but also talking about reversal and providing knowledge and support to achieve it, according to Hallberg.
3. After 20 Years of Watching Diabetes Tech, Kliff Eyes Smart Insulin Pens, CGM for Patients With Type 2 Diabetes
In an interview with Evidence-Based Diabetes Management™, David Kliff, who has run Diabetes Investor since he was diagnosed with the condition more than 20 years ago, explained that widespread improvement will come with new medications and novel technologies that dramatically reduce the pain and complexity of proper self-care. He believes that better tools can produce better outcomes, that several significantly better tools have recently hit the market, and that more are coming soon.
2. Contributor: Driving Value With Innovative Approaches to Colon Cancer Screenings (Jim Thomson)
In addition to the low compliance rate of colorectal screenings, Thomson’s article also discussed value as a driver of the managed care business. The industry is constantly in pursuit of new technologies, procedures, and strategies that deliver the highest quality of care while controlling cost, according to Thompson, and as part of this, we regularly advocate for preventive care services known to improve outcomes for patients and deliver long-term gains.
1. 2017 Sees Progress in Approvals for Anti-Rheumatic Drugs
Coverage from the American College of Rheumatology 2017 Annual Meeting included an overview of the drugs that have been approved this past year for the treatment of inflammatory conditions. These drugs include brodalumab (Siliq) for the treatment of moderate to severe plaque psoriasis, methotrexate (Xatmep) for the treatment of polyarticular juvenile idiopathic arthritis, and sarilumab (Kevzara) for the treatment of adults with moderate to severe rheumatoid arthritis.
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Community Engagement, Culturally Tailored Care as a Gateway to Advancing Health Equity
October 16th 2024Many talks at the Association of Cancer Care Centers (ACCC) 41st National Oncology Conference advocated for the adoption of culturally relevant care, the leveraging of community partnerships, and community engagement to build better trust with patients and improve outcomes.
Read More
Combatting Misconceptions of Clinical Trials to Improve Patient Participation
October 16th 2024There are many misconceptions patients might have about clinical trials that prevent them from participating, and it’s important to understand what they are in order to overcome them, said Terry L. Keys, of University of Kentucky Markey Cancer Center.
Read More
